|
|
 |
|
Advocates for justice, consumer access to the courts, and accountable government
|
|
||||
|
|
 |
|
||||
|
|
  PhRMA’s Secret Playbook: "Insider" Documents Show Prescription Drug Industry Continues Campaign to Undermine Support for a Prescription Drug BenefitAfter spending $30 million in 1999 on ads intended to undermine support for an outpatient prescription drug benefit for Medicare recipients, two spokesman for the prescription drug industry's main trade group, the Pharmaceutical Research and Manufacturers of America (PhRMA), recently told The New York Times that they would accept legislation to provide Medicare drug benefits this year ("Drug Makers Drop Their Opposition to Medicare Plan," January 14).
However, just five days after the article was published, on January 19, PhRMA's "Public Affairs Section" held a strategy meeting with their allies detailing plans that appear designed to undermine support for a Medicare prescription drug bill. PhRMA's battle plan includes a Calendar of Events for January and February, as well as other documents, revealing that the industry's strategy is to work in a highly coordinated way with allied organizations and "front" groups. Their activities include releasing reports, conducting a major grassroots public relations and lobbying campaign, initiating state media tours to challenge increased publicity about how much cheaper drugs are in Canada, and opposing the "Allen" bill (H.R. 664/S. 731), which is the most popular Medicare prescription drug bill in Congress. Specifically, PhRMA and its allies will: 1) Undertake a Major Grassroots Public Relations and Lobbying Campaign In mid-January PhRMA ads were to begin running and Citizens for Better Medicare (CBM), a "front group" formed and largely if not exclusively funded by PhRMA to lobby on the prescription drug issue, also was to begin running ads again after letting up at the end of last year. (Trade publications previously reported that up to $35 million in additional ads were to run in 2000.) Moreover, a major direct mail and phone bank operation were to begin, polls were to be released and extensive lobbying of Capitol Hill was to occur. 2) Conduct State Media Tours to Challenge Lower Canadian Drug Prices To counter the growing wave of Americans traveling across the border into Canada to buy the same drugs at a 25% to 50% discount from the prices they pay in the U.S., PhRMA planned to begin state media tours in key border states in late January. Targeted states were Maine, Massachusetts, Michigan, Minnesota, Montana, Oregon, Vermont, and Washington. In early February, state media tours are also planned on "price controls." 3) Intensify Opposition to the Allen Bill The Allen bill is the Prescription Drug Fairness for Seniors Act (H.R. 664/S. 731) sponsored by Reps. Tom Allen (D-Maine) and Henry Waxman (D-Calif.) in the House and Sens. Tim Johnson (D-S.D.) and Edward Kennedy (D-Mass.) in the Senate. The legislation is the most popular Medicare prescription drug bill in Congress with 138 House cosponsors and 12 Senate cosponsors as of January 24, 2000. The Allen bill will allow 39 million Medicare beneficiaries to buy prescription drugs at up to 40% off current retail prices. A June 1999 Merrill Lynch report found that at most the impact of the legislation would be to cut drug company revenues by only 3.3% — a modest cut given the enormous profits generated by the industry. 4) Release reports by allies and "front groups" to bolster the industry's position As revealed by the Calendar of Events, the reach of PhRMA is substantial when it comes to working with some of Washington's most influential conservative think tanks and advocacy organizations, many of whom receive substantial financial support from PhRMA and allied corporate patrons. Here is a list of scheduled activities on the PhRMA Calendar of Events (an asterisk * indicates membership in Citizens for Better Medicare): January 10 - "Goldberg Study: Canada access; HIAA [Health Insurance Association of America] Hill briefing: drug costs." The latter reference appears to be Dr. Robert Goldberg, whose January 17 communication with PhRMA seeking financial support is discussed below.
lobbyist for the Health Benefits Coalition in 1998, the most recent year for which online records are available on the Center for Responsive Politics' website. According to its mission statement, the HBC was "formed out of concern that federal health care mandates proposed in Congress under the guise of ‘patient protections' would increase health care costs…" Tozzi, a former senior official at the Office of Management and Budget (OMB) during the Reagan and Carter administrations, previously has worked to discredit the risk of second hand smoke on behalf of Phillip Morris and its allies. Moreover, two communications contained in the PhRMA meeting documents shed some light on how PhRMA sponsors, or considers sponsoring, supposedly objective researchers and commentators: January 7, 2000 — Betsey McCaughey Ross, senior fellow at the Hudson Institute, wrote a letter to Alan Holmer, PhRMA President and CEO, in advance of a scheduled meeting "asking PhRMA to support my work at the Hudson Institute, because my writings on health care policy can make a substantial difference in public opinion and in the nation's capitol. My track record proves it." McCaughey is the former Lieutenant Governor of New York State under Governor George Pataki. January 17, 2000 — Dr. Robert Goldberg, senior research fellow at the Ethics and Public Policy Center, sent a memorandum to Alixe Mattingly, PhRMA's senior vice president for public affairs, noting that "last year I put out a steady stream of articles (see attached samples), did dozens of radio interviews and participated in a number of live and televised forums on the issue of prescription drug coverage...Ironically I have been so busy that I have not had time to reach out to the right people for such additional funding. So now I am asking your help to help me contact the appropriate individuals in various companies to support my research and writing." more resources
Because Public Citizen does not accept funds from corporations, professional associations or government agencies, we can remain independent and follow the truth wherever it may lead. But that means we depend on the generosity of concerned citizens like you for the resources to fight on behalf of the public interest. If you would like to help us in our fight, click here. |
|
Join | Contact PC | Contribute | Site Map | Careers/Internships| Privacy Statement | |||